Literature DB >> 31977960

Exploring Clinically-Relevant Experimental Models of Neonatal Shock and Necrotizing Enterocolitis.

Lila S Nolan1, James L Wynn2, Misty Good1.   

Abstract

Neonatal shock and necrotizing enterocolitis (NEC) are leading causes of morbidity and mortality in premature infants. NEC is a life-threatening gastrointestinal illness, the precise etiology of which is not well understood, but is characterized by an immaturity of the intestinal barrier, altered function of the adaptive immune system, and intestinal dysbiosis. The complexities of NEC and shock in the neonatal population necessitate relevant clinical modeling using newborn animals that mimic the disease in human neonates to better elucidate the pathogenesis and provide an opportunity for the discovery of potential therapeutics. A wide variety of animal species-including rats, mice, piglets, and primates-have been used in developing experimental models of neonatal diseases such as NEC and shock. This review aims to highlight the immunologic differences in neonates compared with adults and provide an assessment of the advantages and drawbacks of established animal models of both NEC and shock using enteral or intraperitoneal induction of bacterial pathogens. The selection of a model has benefits unique to each type of animal species and provides individual opportunities for the development of targeted therapies. This review discusses the clinical and physiologic relevance of animal models and the insight they contribute to the complexities of the specific neonatal diseases: NEC and shock.

Entities:  

Mesh:

Year:  2020        PMID: 31977960      PMCID: PMC7376956          DOI: 10.1097/SHK.0000000000001507

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.533


  95 in total

1.  Animal models of gastrointestinal and liver diseases. Animal models of necrotizing enterocolitis: pathophysiology, translational relevance, and challenges.

Authors:  Peng Lu; Chhinder P Sodhi; Hongpeng Jia; Shahab Shaffiey; Misty Good; Maria F Branca; David J Hackam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-24       Impact factor: 4.052

Review 2.  Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny.

Authors:  Tobias R Kollmann; Beate Kampmann; Sarkis K Mazmanian; Arnaud Marchant; Ofer Levy
Journal:  Immunity       Date:  2017-03-21       Impact factor: 31.745

Review 3.  Innate immunity in human newborn infants: prematurity means more than immaturity.

Authors:  Tobias Strunk; Andrew Currie; Peter Richmond; Karen Simmer; David Burgner
Journal:  J Matern Fetal Neonatal Med       Date:  2010-06-23

Review 4.  Innate and adaptive immunity in necrotizing enterocolitis.

Authors:  Madison A Mara; Misty Good; Joern-Hendrik Weitkamp
Journal:  Semin Fetal Neonatal Med       Date:  2018-08-17       Impact factor: 3.926

5.  Racial/ethnic differences in necrotizing enterocolitis incidence and outcomes in premature very low birth weight infants.

Authors:  Momodou L Jammeh; Obinna O Adibe; Elisabeth T Tracy; Henry E Rice; Reese H Clark; P Brian Smith; Rachel G Greenberg
Journal:  J Perinatol       Date:  2018-08-07       Impact factor: 2.521

6.  Porcine peritoneal sepsis: modeling for clinical relevance.

Authors:  K K Kazarian; P W Perdue; W Lynch; A Dziki; J Nevola; C H Lee; I Hayward; T Williams; W R Law
Journal:  Shock       Date:  1994-03       Impact factor: 3.454

7.  Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18.

Authors:  James Lawrence Wynn; Chris S Wilson; Jacek Hawiger; Philip O Scumpia; Andrew F Marshall; Jin-Hua Liu; Irina Zharkikh; Hector R Wong; Patrick Lahni; John T Benjamin; Erin J Plosa; Jörn-Hendrik Weitkamp; Edward R Sherwood; Lyle L Moldawer; Ricardo Ungaro; Henry V Baker; M Cecilia Lopez; Steven J McElroy; Natacha Colliou; Mansour Mohamadzadeh; Daniel Jensen Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

8.  Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000.

Authors:  Li Liu; Hope L Johnson; Simon Cousens; Jamie Perin; Susana Scott; Joy E Lawn; Igor Rudan; Harry Campbell; Richard Cibulskis; Mengying Li; Colin Mathers; Robert E Black
Journal:  Lancet       Date:  2012-05-11       Impact factor: 79.321

9.  A Neonatal Murine Model of MRSA Pneumonia.

Authors:  Elizabeth A Fitzpatrick; Dahui You; Bishwas Shrestha; David Siefker; Vivek S Patel; Nikki Yadav; Sridhar Jaligama; Stephania A Cormier
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

10.  Survival, bacterial clearance and thrombocytopenia are improved in polymicrobial sepsis by targeting nuclear transport shuttles.

Authors:  Ruth Ann Veach; Yan Liu; Jozef Zienkiewicz; Lukasz S Wylezinski; Kelli L Boyd; James L Wynn; Jacek Hawiger
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

View more
  4 in total

Review 1.  The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers.

Authors:  Emily Hensler; Habesha Petros; Chyna C Gray; Chun-Shiang Chung; Alfred Ayala; Eleanor A Fallon
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 2.  Use of Translational, Genetically Modified Porcine Models to Ultimately Improve Intestinal Disease Treatment.

Authors:  Cecilia R Schaaf; Liara M Gonzalez
Journal:  Front Vet Sci       Date:  2022-05-20

3.  Editorial: Immunity in Compromised Newborns.

Authors:  Per T Sangild; Tobias Strunk; Andrew J Currie; Duc Ninh Nguyen
Journal:  Front Immunol       Date:  2021-07-26       Impact factor: 7.561

4.  Neutrophil extracellular trap inhibition increases inflammation, bacteraemia and mortality in murine necrotizing enterocolitis.

Authors:  Hala Chaaban; Kathryn Burge; Jeffrey Eckert; Ravi S Keshari; Robert Silasi; Cristina Lupu; Barbara Warner; Marilyn Escobedo; Michael Caplan; Florea Lupu
Journal:  J Cell Mol Med       Date:  2020-06-08       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.